Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-23

Clinical Trial Update: Terconazole Vaginal Suppository vs Fluconazole for the Treatment of Severe Vulvovaginal Candidiasis [Phase 4]

View source ↗

Summary

Phase 4 trial comparing terconazole vaginal suppository to fluconazole for severe vulvovaginal candidiasis completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluconazole (Fluconazole)
  • Terconazole (Terconazole)

Snippet

Sponsor: Peking University Shenzhen Hospital | Conditions: Vulvovaginal Candidiasis | Phase 4 | Status: COMPLETED | Results posted: 2020-10-23